Tehran University of Medical Sciences
Office of Vice-Chancellor for Global Strategies & International Affairs
International Human Capacity Development (IHCD)
Code : 9345-345843      Publish Date : Tuesday, March 17, 2015 Visit : 2107

Intl. Congress form | International Congress Report | International Congress Report For Faculty | 4th European Headache and Migraine Trust International Congress – EHMTIC 2014

4th European Headache and Migraine Trust International Congress – EHMTIC 2014
The report of 4th European Headache and Migraine Trust International Congress – EHMTIC 2014 by Dr. Mansoureh Togha
 
Application Code :
306-0214-0109
 
Created Date : Sunday, October 5, 2014 18:43:12Update Date : Monday, March 16, 2015 12:11:50
IP Address : 2.188.26.192Submit Date : Monday, March 16, 2015 12:12:26Email : toghae@sina.tums.ac.ir
Personal Information
Name : Mansoureh
Surname : Togha
School/Research center : School of Medicine
If you choose other, please name your Research center :  
Possition : Professor
Tel : +98-21-66348500
Information of Congress
Title of the Congress : 4th European Headache and Migraine Trust International Congress – EHMTIC 2014
Title of your Abstract : EFFICACY AND SAFETY OF VENLAFAXINE FOR THE TREATMENT OF CHRONIC MIGRAINE: A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL
country : Denmark
From : Thursday, September 18, 2014
To : Sunday, September 21, 2014
Abstract(Please copy/paste the abstract send to the congress) : Introduction
Chronic migraine (CM) is a disabling neurological disorder
that is defined in different ways. Treatment of CM is
difficult and needs multidisciplinary approach. To date,
minimal study of chronic migraine treatment has been
done and few medications are suggested to improve
headache duration and intensity in chronic migraine.
Different studies demonstrated that topiramate at a dose
of 100 mg/day, can reduce migraine days in CM patients
when compared with placebo.
Aims
The purpose of this double-blind, randomized trial was
to evaluate and compare the effects of extended-release
venlafaxine with topiramate in patients with chronic
migraine and medication overuse headache (MOH) to
investigate whether venlafaxine could be at least as
effective as topiramate.
Methods
Chronic migraine was defined according to the criteria
of the Headache Classification Committee of the International
Headache Society (IHS). A prospective, 4-week
run-in phase was followed by a 12-week treatment
phase which consistent of a 4-week titration and 8-week
maintenance period.
Results
There was no statistically significant difference in terms
of primary or secondary efficacy measures between
topiramate-group and venlafaxine-group during the
double-blind period.
Conclusions
In this double-blind, randomized study extended-release
venlafaxine 150 mg/day found to be effective in chronic
migraine. Our study showed a clear effect that was in
subgroup of subjects with medication overuse. In addition,
in this study, the low number of adverse events
showed venlafaxine to be well tolerated. Future controlled
trials expended longer with larger sample size,
should also support the effectiveness and safety of venlafaxine
in patients suffering from chronic migraine.
No conflict of interest.
Keywords of your Abstract : chronic migraine, venlafaxine, topiramate
Acceptance Letter :
The presentation : Poster
The Cover of Abstract book :
Published abstract in the abstract book with the related code :
Where has your abstract been indexed? : ISI
If you choose other, please name :  
The Congress Reporting Form
How many volunteers were present at the Congress? : more than 1000
Delegates from which countries presented in the congress? : The participants were from more than 75 contraries (Germany, Spain, France, Italy, Sweden, ...) and the recent researches from many of these countries were presented.
Were the delegates of any other organizations present in the congress? : Yes
If yes, please write the names of the organizations in the box : migraine trust and european headache organization
What were the responses to your talking points? Were specific questions or concerns raised? : I have negotiated with prof.olsen and prof.godsby, and prof.ashina about the scientific program in Iran and fellowship student exchange, as well as, cooperation for having teaching courses in Iran
If you met staff members, please list their full names & positions. : prof.olsen and prof.godsby, prof.ashina
Please inform us if there are any follow up actions we need to talk with the members of the congress : University support is needed for managing teaching courses and scientific exchanging programs. .
Your experiences about the travel processes(Providing ticket, accommodation,...) : The accommodation was chosen in a way to be compatible with the grant
Please give a briefing of your own observations and outcomes of the congress: : My information about headache classification, intractable and cluster headache was updated. . .